Combined targeting of BCL2 (using ABT199) and the myeloid cell lymphoma-1 (MCL1) protein (using S63845) inhibits the proliferation of CBFA2T3::GLIS2 cells in vitro and abrogates leukemia progression in mouse xenografts (Aid et al., 2023). This evidence concerns the gene GLIS2 and leukemia.